CheckMyRecalls

Exela Pharma Sciences LLC recalls .2% Sodium Bicarbonate Injection

Published
17 Sept 2025
Units affected
N/A
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC, Lenoir, NC 28645 USA, NDC 51754-5012-1 (vial); 51754-5012-4 (carton)

Brand / company
Exela Pharma Sciences LLC
Codes / lots
Lot # 10004077, Exp. 02/28/2026
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 17 Sept 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.